The keys that can turn Spain into a reference for biomedical research

Source: www.20minutos.es Our country is one of the best conditions to host biomedical and pharmaceutical research projects, both national and international. In 1886, scientists Oskar Minkowski and Josef Mering discovered the importance of the pancreas as a gland that controlled blood glucose, a fact that laid the groundwork to boost the treatment of diabetes. In […]

The pharmaceutical industry accelerates against lung cancer, the one with the highest mortality in Spain

One in five clinical trials in Oncology in our country investigates this type of tumor, which causes 22,000 deaths per year The available treatments have tripled in the last two decades   Source: www.Farmaindustria.es Lung cancer is currently the cancer disease with more open research by the pharmaceutical industry in Spain in search of new […]

“We have put the name of Vall d’Hebron on the map of world oncology”

  Source: www.immedicohospitalario.es Such a high percentage of participation in clinical research studies has no one. The Vall d’Hebron Institute of Oncology (VHIO) is a research institute focused on cancer that covers the preclinical, translational and clinical areas. Having access to a large hospital, with a large number of patients, has helped very importantly in […]

Andalusian high school students are interested in drug R&D

The Maternal and Child Hospital of Malaga hosted on Wednesday a new edition of the day ‘Bringing science closer to schools. Drug research and development ’, organized by the Biomedical Research Institute (Ibima) and Pharmaindustry Source: www. farmaindustria.es Some 160 high school and vocational students from various institutes in Malaga attended a new edition, the […]

Farmaindustria reinforces the collaboration to promote clinical research in Spain

Meeting with hospital pharmacists to exchange knowledge and experience between industry and professionals to promote trials It was agreed to establish a mixed working group to continue the dialogue and continue to improve the quality of clinical studies. Source: www.farmaindustria.es Farmaindustria held this Wednesday at the Royal National Academy of Pharmacy (RANF), in Madrid, the […]

#WeWontRest until we beat Alzheimer’s disease – together

Source: www.epfia.eu Unlocking the mystery behind Alzheimer’s disease and dementia and improving care for people require new types of partnership. As we navigate uncertain waters, we need to come together to explore the opportunities and barriers that arise and #WeWontRest until we beat Alzheimer’s disease – together. On 23-25 October, I attended the Alzheimer Europe (AE) […]

The pharmaceutical industry reaffirms its commitment to R&D in rare diseases

The number of new treatments available against rare pathologies has multiplied by 20 in Europe since 2000 The industry insists on collaboration with governments and health systems to facilitate patients’ access to medicines Pharmaindustry joins the new phase of the European initiative #WeWontRest, focused on rare diseases Source: www.farmaindustria.es “We will not rest until treatments […]

The pharmaceutical industry already invests more than 660 million euros a year in clinical research in Spain

It is one of the keys that explain why Spain has become one of the countries in Europe with better conditions to develop clinical trials of new medicines The investment has grown 121% in the last 15 years, says Farmaindustria at the Innova Health Congress 2019, in Madrid Source: www.farmaindustria.es The pharmaceutical industry with activity […]

Investment in R&D of the pharmaceutical industry, a value for the whole society

Experts from the Weber Foundation and Farmaindustria clear some doubts about drug spending and analyze research challenges. Source: www.farmaindustria.es The pharmaceutical sector is high risk; For sample, a fact: of every ten new medicines only three recover the investment in R&D made by the companies. However, this constant investment in research translates into health, economic […]

The pharmaceutical industry has in the R&D phase 140 new medicines against mental disorders

To the suffering of patients and relatives there are costs that in the European Union equal 4% of the GDP of the member countries This Thursday marks the World Mental Health Day, focused on suicide prevention Source: www.farmaindustria.es The pharmaceutical industry currently has 140 new treatments focused on the field of psychiatric diseases, according to […]